Pro-Dex, Inc. (PDEX)
61.15
-0.95
(-1.53%)
USD |
NASDAQ |
Sep 01, 14:54
Pro-Dex Total Long Term Debt (Quarterly) : 19.33M for March 31, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 19.33M |
| December 31, 2025 | 10.89M |
| September 30, 2025 | 13.80M |
| June 30, 2025 | 16.08M |
| March 31, 2025 | 19.10M |
| December 31, 2024 | 17.33M |
| September 30, 2024 | 14.55M |
| June 30, 2024 | 13.09M |
| March 31, 2024 | 13.04M |
| December 31, 2023 | 13.49M |
| September 30, 2023 | 12.94M |
| June 30, 2023 | 14.38M |
| March 31, 2023 | 14.11M |
| December 31, 2022 | 14.55M |
| September 30, 2022 | 15.17M |
| June 30, 2022 | 15.59M |
| March 31, 2022 | 14.37M |
| December 31, 2021 | 14.41M |
| September 30, 2021 | 14.81M |
| June 30, 2021 | 15.20M |
| March 31, 2021 | 15.20M |
| December 31, 2020 | 11.46M |
| September 30, 2020 | 6.469M |
| June 30, 2020 | 6.684M |
| March 31, 2020 | 6.948M |
| Date | Value |
|---|---|
| December 31, 2019 | 7.183M |
| September 30, 2019 | 7.414M |
| June 30, 2019 | 4.556M |
| March 31, 2019 | 4.713M |
| December 31, 2018 | 4.869M |
| September 30, 2018 | 5.033M |
| June 30, 2018 | 0.041M |
| March 31, 2018 | 0.05M |
| December 31, 2017 | 0.091M |
| September 30, 2017 | 0.105M |
| June 30, 2017 | 0.119M |
| March 31, 2017 | 0.133M |
| December 31, 2016 | 0.148M |
| September 30, 2016 | 0.161M |
| June 30, 2016 | 0.072M |
| March 31, 2016 | 0.076M |
| December 31, 2015 | 0.581M |
| September 30, 2015 | 0.593M |
| June 30, 2015 | 0.101M |
| March 31, 2015 | 0.109M |
| December 31, 2014 | 0.012M |
| September 30, 2014 | 0.013M |
| June 30, 2014 | 0.015M |
| March 31, 2014 | 0.016M |
| December 31, 2013 | 0.019M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Abbott Laboratories | 32.61B |
| AngioDynamics, Inc. | 9.66M |
| Alphatec Holdings, Inc. | 597.42M |
| AtriCure, Inc. | 72.53M |
| Baxter International, Inc. | 8.857B |